Skip to main content

Table 3 Percent difference of the simplified methods for absorbed dose calculations and the effective half-lives

From: Kidney dosimetry in 777 patients during 177Lu-DOTATATE therapy: aspects on extrapolations and measurement time points

 

Left kidney

Right kidney

Percent difference in Absorbed dose

AD147 vs AD14

− 2.5 (− 20.1–71.8)

− 2.6 (− 39.6–52.4)

AD147 vs AD17

2.9 (− 21.6–29.6)

2.8 (− 17.7–31.4)

AD147 vs AD4/52

− 6.4 (− 51.0–27.4)

− 6.0 (− 59.2–27.3)

AD147 vs AD4/H

− 3.3 (− 45.5–31.2)

− 3.1 (− 57.9–29.8)

AD14 vs AD4/52

− 2.9 (− 67.5–4.5)

− 2.6 (− 63.3–4.8)

AD14 vs AD4/H

0.0 (− 62.3–6.1)

0.4 (− 58.3–6.0)

Percent difference in effective half-lives

teff,147 vs teff,14

− 8.8 (− 79.1–89.4)

− 8.6 (− 87.6–66.0)

teff,147 vs teff,17

0.0 (− 8.5–4.0)

0.0 (− 8.5–4.3)

  1. Data are presented as median (range)